Tag: hypertension

Virtual ACC: Renal denervation bests sham control to safely lower blood...

Three months after undergoing renal denervation, patients with untreated high blood pressure had statistically significant reductions in average blood pressure over 24 hours compared...

Acceleron announces sotatercept achieved primary and secondary endpoints in the PULSAR...

Acceleron Pharma today announced that the PULSAR Phase 2 trial of sotatercept met its primary and key secondary endpoints in patients with pulmonary arterial...

TARGET BP I trial enrols its first patient

The first patient has been randomised in the TARGET BP I trial at the Piedmont Heart Institute in Atlanta, USA, to investigate the use...
RADIANCE-HTN ReCor Medical

ReCor Medical completes RADIANCE-HTN SOLO hypertension study

ReCor Medical announced today randomisation of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's study of its Paradise...

First procedure performed in Rox Medical’s CONTROL HTN-2 clinical trial

The first patient was treated in the CONTROL hypertension (HTN)-2 clinical study, the Rox Medical’s pivotal study to evaluate the safety and effectiveness of...